Quick Facts: Primary Therapeutic Uses

• Temporary relief of symptoms associated with the common cold or flu.
• Management of minor aches and pains, and reduction of elevated body temperature (fever).
• Relief of nasal and sinus congestion.

---

What Niofen Cold Treats: Main Uses and Benefits

Niofen Cold is a medicinal preparation intended for the temporary relief of a collection of symptoms frequently associated with the common cold, influenza (flu), and other related upper respiratory tract conditions. Its primary therapeutic goal is to alleviate patient discomfort during the course of these self-limiting illnesses.

Key uses include the symptomatic management of minor aches and pains, such as headache and body aches, and the reduction of elevated body temperature, commonly known as fever. Additionally, the medication is employed to provide relief from nasal and sinus congestion, which assists in improving respiratory comfort.

Patients should use this product only as directed, for the short-term relief of these specific symptoms. Combination products for cold symptom relief are utilized for their integrated actions against pain and fever. If symptoms persist or worsen, consulting a healthcare provider is recommended.

Regulatory References

1. EMA therapeutic overview

The use of this combination medicine, which contains ibuprofen (an NSAID) and pseudoephedrine (a decongestant), is strictly defined by regulatory guidelines based on a patient’s health status, age, and concurrent medications.

Contraindicated Populations (Must Not Use)

Official regulatory documents define absolute contraindications for patients with:

• Hypersensitivity or Allergic Reactions: A known allergy to ibuprofen, pseudoephedrine, aspirin, or other NSAIDs.
• Gastrointestinal Conditions: Active or a history of recurrent peptic ulcers, gastrointestinal bleeding, or perforation (related to previous NSAID therapy).
• Severe Organ Dysfunction: Severe or uncontrolled hypertension, severe coronary heart disease, severe heart failure, or severe hepatic (liver) or renal (kidney) failure.
• Specific Conditions/Drug Interactions: Phaeochromocytoma, or patients currently taking Monoamine Oxidase Inhibitors (MAOIs) or within 14 days of stopping MAOI treatment.

Age and Physiological Restrictions

• Children: Use is not recommended and is generally prohibited for children under 12 years of age.
• Pregnancy: The medicine is contraindicated during the last trimester of pregnancy.
• Elderly: While eligible, caution is often advised for older adults due to an increased risk of gastrointestinal issues.

Caution and Restricted Use

Use requires special consideration and caution from a healthcare professional for individuals with pre-existing conditions such as: mild to moderate cardiovascular disease, diabetes, hyperthyroidism, glaucoma, or a history of peptic ulcer disease.

Interactions with other medicines and products

Niofen Cold is a fixed-dose combination; its interaction profile reflects the separate risks of Ibuprofen (NSAID) and Chlorpheniramine (antihistamine), as documented in regulatory sources.

Formally Restricted Combinations

Certain combinations are listed in regulatory documents with mandatory constraints or prohibitions:

• Monoamine Oxidase Inhibitors (MAOIs): Use is prohibited during or within 14 days of discontinuing MAOI therapy due to the risk of severe additive effects from Chlorpheniramine.
• Other NSAIDs: The co-administration of Niofen Cold with any other Nonsteroidal Anti-Inflammatory Drug is generally avoided or contraindicated due to a documented increase in the risk of serious gastrointestinal events.
• CABG Surgery: Use for peri-operative pain right before or after Coronary Artery Bypass Graft surgery is contraindicated.

️ Interactions with Medicines and Products

This medication has documented interactions with several classes of products and specific medicines:

Category	Documented Interaction Risk	Basis in Regulatory Information
CNS Depressants	Additive sedative effects.	Applies to alcohol, tranquilizers, and sedatives due to the Chlorpheniramine component.
Anticoagulants	Increased risk of gastrointestinal bleeding.	Applies to agents like warfarin and co-administration with corticosteroids or anti-platelet agents.
Anti-hypertensives	Reduced therapeutic effectiveness.	Applies to certain anti-hypertensive drugs, including ACE inhibitors and diuretics.
Specific Agents	Altered drug levels.	Ibuprofen may decrease the elimination of Lithium and inhibit the renal clearance of Methotrexate.

How Niofen Cold Works: Mechanistic Overview

Niofen Cold exerts its effect by engaging distinct enzyme- and receptor-mediated signaling pathways. Its action can be segmented into two core mechanistic domains, targeting both inflammatory mediator cascades and vascular responses.

Modulation of Prostaglandin-Mediated Signaling

This domain focuses on the non-selective inhibition of cyclooxygenase (COX) enzymes , which are crucial for the synthesis of prostaglandins. By modifying these early molecular steps, the drug acts within pathways associated with heightened physiological responses. This mechanism modulates the activity level within targeted pathways, contributing to the modulation of prostaglandin-mediated thermal and pain-signaling responses.

---

Alpha-Adrenergic Receptor Agonism

This domain involves the component that acts as an alpha-adrenergic receptor agonist, engaging mechanisms that regulate vascular processes. By initiating specific signaling sequences on smooth muscle cells in the nasal mucosa, the drug modifies pathway activity that may escalate under certain conditions. This engagement leads to localized vasoconstriction, which limits the impact of excessive fluid accumulation, resulting in a reduction of tissue engorgement and fluid leakage .

How to Use Niofen Cold: Administration Guidelines

Niofen Cold, a fixed-dose combination product containing Ibuprofen and Chlorpheniramine, is administered according to specific procedural instructions. The primary focus of these instructions is the oral route of administration, adhering strictly to defined dosage units, frequency, and time limits.

---

Administration Protocol

Instruction	Details
Route of administration	Oral administration only. The product is a tablet designed to be swallowed whole.
Standard Dosing Schedule	Adults and adolescents 12 years of age and older should take 1 tablet per dose. The maximum allowable daily intake is 6 tablets in any 24-hour period.
Frequency and Interval	Dosing should occur on an as-needed basis, with a minimum interval of 4 to 6 hours between administrations.
Timing with Meals	The tablet may be taken with food or milk if the patient experiences stomach sensitivity, a common contextual instruction for NSAID-containing medicines.
Age Restriction	Use is not approved for children under 12 years of age.

---

Duration and Use Constraints

The medication is intended for short-term use only for temporary symptomatic relief. Procedural constraints apply for the duration of use. If fever persists for more than 3 days, or if pain or other symptoms persist for more than 7 days, the usage should be discontinued and reviewed by a healthcare professional. The entire protocol mandates using the lowest effective dose and strictly adhering to the maximum 24-hour limit.

Research Evidence / Overview of Studies for Niofen Cold

This overview summarizes the clinical research available for this combination medicine, focusing on the design of the studies, the outcomes that were measured, and the populations that participated. This research contributes to the broader understanding of how combination cold medicines are evaluated by regulators and scientific bodies.

---

Evidence for Use in Symptomatic Relief of Common Cold/Flu-like Illness

Research examining outcomes related to physical discomfort during cold and flu symptoms typically consists of short-term Randomized Controlled Trials (RCTs) and systematic reviews. These studies were used in research exploring how symptoms change over time when participants use the combination preparation compared to either a placebo or a single active ingredient.

Researchers explored outcomes related to physical discomfort by tracking composite symptom severity scores. Findings describe patterns observed in the studies and focused on the acute phase of illness. The study consistency is generally described as moderate.

---

Evidence for Management of Systemic Symptoms (Pain and Fever)

Systemic symptoms like body aches, headache, and fever were evaluated in numerous trials. Research for this specific purpose utilizes the scientific evidence available for the Ibuprofen component, which is internationally recognized for its function in addressing outcomes related to systemic or functional imbalance.

Studies monitored changes in body temperature and pain intensity reduction in Adults and Adolescents. The study consistency is generally described as high, supported by the established evidence for the pain-relieving component.

---

Evidence for Relief of Allergic-Type Nasal Symptoms

The antihistamine component, Chlorpheniramine, was evaluated in trials assessing short-term or episodic symptom patterns associated with cold or flu. Research examined outcomes linked to inflammatory or irritative states, such as sneezing frequency, runny nose, and watery eyes. The study consistency for this area is generally described as moderate.

---

What is Still Uncertain About Niofen Cold Research

Areas where research is ongoing or where certainty remains low include:

• The specific comparative evidence examining how the dual combination was evaluated in relation to a triple combination (which includes a decongestant).
• Subgroup findings are uncertain for specific populations, such as younger children or older adults.
• Long-term effects are not fully established because the follow-up durations were naturally limited to the acute phase of the cold.
• The evaluation of the antihistamine component to systemic symptoms (pain/fever) is not always clearly isolated in the research.

Key Studies & References Chlorpheniramine: Drug Information

Proper storage ensures the medication maintains its effectiveness and safety. Niofen Cold should be stored at room temperature, generally between 59 F to 77 F (15 C to 25 C), in a cool, dry place.

Storage Guidelines

• Keep the medicine in its original container and away from moisture, heat, and direct light. Do not store it in the bathroom or near a kitchen stove or sink, as fluctuations in temperature and humidity can damage the product.
• Always store all medicines, including Niofen Cold, securely out of the sight and reach of children and pets.

Disposal

• Dispose of any expired or unused medicine promptly. Check the expiration date regularly.
• The best method of disposal is through a community drug take-back program or a pharmacy-based collection program.
• If no take-back program is available, you may dispose of the medicine in your household trash by mixing it with an unappealing substance like used coffee grounds or cat litter, placing the mixture in a sealed bag or container, and then discarding it. Do not crush tablets.
• Do not flush Niofen Cold down the toilet or pour it down a sink unless specifically instructed by the labeling or a healthcare professional.